Indian Bank’s Q3FY26 performance underscores a phase of measured consolidation rather than aggressive expansion.
News in Focus
Dr Reddy’s Laboratories is navigating a critical transition phase as legacy gains from gRevlimid taper off, even as the company lays the groundwork for its next multi-year growth cycle.
UltraTech Cement, India’s largest cement manufacturer, continues to outpace industry growth as capacity expansion, operational efficiencies, and infrastructure-led demand converge into a multi-year
Featured, Analyst View, Stock Markets, BP Equities, Gujarat, Gujarat Themis Biosyn, India, Pharmaceutical Sector
Gujarat Themis Biosyn Limited (GTBL), a niche pharmaceutical manufacturer specializing in fermentation-based intermediates, is entering a decisive phase of strategic evolution. BP Equities Pvt.
Motilal Oswal Financial Services has reiterated a BUY call on Suzlon Energy, arguing that the recent correction in the stock has created a compelling risk-reward setup at a time when India’s renewa
ICICI Direct has reiterated its BUY recommendation on SRF Limited, setting a 12-month target price of Rs 3,315, implying an upside of 21 percent from current levels.
Main Regional Stories
Cyient DLM Limited’s Q3FY26 performance reflected a transitional phase rather than a deterioration in business fundamentals.
Jindal Steel Limited has entered a critical inflection point where long-term capacity expansion, improving balance-sheet metrics, and a confirmed technical breakout are beginning to align.
Supreme Industries Limited (SIL) delivered a mixed Q3FY26 performance, broadly meeting revenue expectations but falling short on profitability as fluctuating polymer prices resulted in inventory losses that compressed margins.
Orient Electric is entering a decisive phase in its growth cycle, marked by accelerating appliances demand, sustained market-share gains in fans, and an improving profitability trajectory after a period of margin compression.
